Health News
Protective Partners for Arthritis Drugs
Some drugs used to relieve the pain of arthritis can do damage to your digestive tract. This is why many arthritis patients take other medications to protect their digestive system.
Smoking Cigarettes May Trigger ALS
It is common knowledge that smoking cigarettes is bad for you. For those with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, smoking can be especially damaging.
When Migraines Hurt
Having a migraine is enough to deal with on its own, without the worry that it may be a symptom of something bigger.
Pain Depends on the Brain
How can two people have the same injury and yet one fully recover and the other develop chronic pain? Chronic pain affects 116 million Americans each year yet the answers to these questions are not completely understood.
A Brain Pacemaker?
Those with hard-to-treat medical conditions live with a frustrating reality. For some disorders a surgical treatment called deep brain stimulation (DBS) has delivered relief.
Depression Drugs Treat Arthritis Pain
Even if a drug was designed to treat one specific disease, it often happens that the same drug can help patients with other conditions. This seems to be the case with a popular antidepressant drug.
Hormones Linked to Improved Thinking
Drugs are often used to help memory in people with dementia. New research is looking into ways a hormone may help people with dementia too. A recent study found that taking a hormone, which is a natural part of the body’s function, improved thinking skills for elderly people.
Obesity May Speed-Up Cognitive Decline
Keeping a healthy weight has many benefits. Recent research suggests that it may also help keep memory sharp as you age. A recent study looked at people’s weight and other health problems, like high blood pressure or high cholesterol.
Clinical Endpoints Not Met In Alzheimer Drug Study
Pfizer Inc. announced that the co-primary clinical endpoints, change in cognitive and functional performance compared to a placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer’s disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301). Pfizer and Janssen AI are partners in the Alzheimer’s Immunotherapy Program (AIP).
Dementia Protection in Your DNA
Risk for dementia increases as people age and when there is a family history. New research suggests that the ability to avoid dementia may also run in families.